{"id":"NCT01674725","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C","officialTitle":"A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin in Treatment-Experienced Subjects With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection (PEARL-II)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2014-01","completion":"2014-10","firstPosted":"2012-08-29","resultsPosted":"2015-01-06","lastUpdate":"2021-07-12"},"enrollment":187,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Infection"],"interventions":[{"type":"DRUG","name":"ABT-450/r/ABT-267, ABT-333","otherNames":["ABT-450 also known as paritaprevir","ABT-267 also known as ombitasvir","ABT-333 also known as dasabuvir","Viekira PAK"]},{"type":"DRUG","name":"Ribavirin","otherNames":[]}],"arms":[{"label":"ABT-450/r/ABT-267 and ABT-333, Plus RBV","type":"EXPERIMENTAL"},{"label":"ABT-450/r/ABT-267 and ABT-333","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and antiviral activity of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267; ABT-450 also known as paritaprevir; ABT-267 also known as ombitasvir) and ABT-333 (also known as dasabuvir) with and without ribavirin (RBV) in patients with chronic hepatitis C virus genotype 1b (HCV GT1b) infection without cirrhosis.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment; Primary Analyses","timeFrame":"12 weeks after last dose of study drug","effectByArm":[{"arm":"ABT-450/r/ABT-267 and ABT-333, Plus RBV","deltaMin":97.7,"sd":null},{"arm":"ABT-450/r/ABT-267 and ABT-333","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG001","p":null},{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24818763","29377566"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":91},"commonTop":["FATIGUE","HEADACHE","NAUSEA","DIARRHOEA","PRURITUS"]}}